Otsuka’s IgAN Data Top Some Vera Results, But To What End?

 
• By Joseph Haas
  
Kidney
Otsuka and Vera are among the companies looking to bring new IgAN therapies to market
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas